Stocks making the biggest moves premarket: Intel, Target, UnitedHealth and more

Pre-market trading saw significant stock movements following corporate news and analyst actions. UnitedHealth surged 11% after Berkshire Hathaway and other prominent investors disclosed substantial stakes. Conversely, Applied Materials plunged 14% on a weak current-quarter outlook, and Sandisk dropped nearly 11% due to a sharp decline in gross margin. Target also fell following a Bank of America downgrade citing a deteriorating long-term outlook and the end of its Ulta Beauty partnership. Meanwhile, Intel climbed over 3% on reports of potential government investment, while Hims & Hers and Rivian also experienced declines on regulatory and revenue-related concerns.

Analysis

Pre-market activity reveals significant divergence driven by company-specific catalysts, with strong institutional conviction in healthcare contrasting with forward-looking weakness in the technology hardware sector. UnitedHealth (UNH) surged 11% on news of a new $1.6 billion stake by Berkshire Hathaway, alongside positions from other notable investors, signaling powerful institutional support that could mark the stock's best performance in five years. Conversely, Applied Materials (AMAT) plummeted approximately 14% after its current-quarter outlook trailed analyst estimates, a bearish signal that overshadowed its third-quarter earnings beat and suggests a potential slowdown for semiconductor equipment. Similarly, Sandisk (SNDK) fell nearly 11% due to a severe contraction in its non-GAAP gross margin from 36.4% to 26.4% year-over-year, indicating significant profitability pressures. In retail, Target (TGT) declined almost 2% following a Bank of America downgrade to 'underperform' and the termination of its partnership with Ulta Beauty, both pointing to a deteriorating long-term outlook. Meanwhile, political and regulatory factors are also key drivers: Intel (INTC) climbed over 3% on reports of potential government investment to fund new factories, while Rivian (RIVN) and Hims & Hers (HIMS) faced declines related to delayed regulatory credit revenue and an FTC investigation into business practices, respectively.

Key Decisions for Investors

• Consider the significant institutional buying in UnitedHealth by prominent investors like Berkshire Hathaway as a strong vote of confidence in the insurer's fundamental value and market position.
• Exercise caution with semiconductor and hardware names like Applied Materials and Sandisk, as weak forward guidance and significant margin erosion suggest potential sector-wide headwinds and pricing pressures.
• Re-evaluate exposure to Target given the combination of an analyst downgrade, a deteriorating competitive outlook, and the termination of its strategic partnership with Ulta, which collectively signal compounding fundamental challenges.
• Monitor political and regulatory developments as a primary risk factor, as a potential government stake provides a specific upside catalyst for Intel while policy shifts and investigations create material downside risk for Rivian and Hims & Hers.